A beta-lactamase preferentially cleaving penicillins. (Dorland, 28th ed) EC 3.5.2.-.
A penicillin derivative commonly used in the form of its sodium or potassium salts in the treatment of a variety of infections. It is effective against most gram-positive bacteria and against gram-negative cocci. It has also been used as an experimental convulsant because of its actions on GAMMA-AMINOBUTYRIC ACID mediated synaptic transmission.
A genus of gram-positive, facultatively anaerobic, coccoid bacteria. Its organisms occur singly, in pairs, and in tetrads and characteristically divide in more than one plane to form irregular clusters. Natural populations of Staphylococcus are found on the skin and mucous membranes of warm-blooded animals. Some species are opportunistic pathogens of humans and animals.
A genus of BACILLACEAE that are spore-forming, rod-shaped cells. Most species are saprophytic soil forms with only a few species being pathogenic.
Nonsusceptibility of an organism to the action of penicillins.
A group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group. The penicillin nucleus is the chief structural requirement for biological activity. The side-chain structure determines many of the antibacterial and pharmacological characteristics. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1065)
Viruses whose host is Staphylococcus.
A species of gram-negative, aerobic bacteria primarily found in purulent venereal discharges. It is the causative agent of GONORRHEA.
Vertical transmission of hereditary characters by DNA from cytoplasmic organelles such as MITOCHONDRIA; CHLOROPLASTS; and PLASTIDS, or from PLASMIDS or viral episomal DNA.
A cephalosporin antibiotic.
A subdiscipline of genetics which deals with the genetic mechanisms and processes of microorganisms.
Acute infectious disease characterized by primary invasion of the urogenital tract. The etiologic agent, NEISSERIA GONORRHOEAE, was isolated by Neisser in 1879.
A species of rod-shaped bacteria that is a common soil saprophyte. Its spores are widespread and multiplication has been observed chiefly in foods. Contamination may lead to food poisoning.
The protoplasm and plasma membrane of plant, fungal, bacterial or archaeon cells without the CELL WALL.
A semi-synthetic antibiotic that is a chlorinated derivative of OXACILLIN.
Enzymes found in many bacteria which catalyze the hydrolysis of the amide bond in the beta-lactam ring. Well known antibiotics destroyed by these enzymes are penicillins and cephalosporins.
Semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic.
One of the PENICILLINS which is resistant to PENICILLINASE but susceptible to a penicillin-binding protein. It is inactivated by gastric acid so administered by injection.
An increase in the rate of synthesis of an enzyme due to the presence of an inducer which acts to derepress the gene responsible for enzyme synthesis.
An antibiotic produced by Streptomyces spectabilis. It is active against gram-negative bacteria and used for the treatment of gonorrhea.
A building block of penicillin, devoid of significant antibacterial activity. (From Merck Index, 11th ed)
The study of the origin, nature, properties, and actions of drugs and their effects on living organisms.
Cephalosporinase is an enzyme produced by certain bacteria that can hydrolyze and confer resistance to cephalosporin antibiotics.
A silver metallic element that exists as a liquid at room temperature. It has the atomic symbol Hg (from hydrargyrum, liquid silver), atomic number 80, and atomic weight 200.59. Mercury is used in many industrial applications and its salts have been employed therapeutically as purgatives, antisyphilitics, disinfectants, and astringents. It can be absorbed through the skin and mucous membranes which leads to MERCURY POISONING. Because of its toxicity, the clinical use of mercury and mercurials is diminishing.
A naphthacene antibiotic that inhibits AMINO ACYL TRNA binding during protein synthesis.
One of the early purine analogs showing antineoplastic activity. It functions as an antimetabolite and is easily incorporated into ribonucleic acids.
An antibiotic similar to FLUCLOXACILLIN used in resistant staphylococci infections.
A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid.
The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).
Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS.
The transfer of bacterial DNA by phages from an infected bacterium to another bacterium. This also refers to the transfer of genes into eukaryotic cells by viruses. This naturally occurring process is routinely employed as a GENE TRANSFER TECHNIQUE.
Acids, salts, and derivatives of clavulanic acid (C8H9O5N). They consist of those beta-lactam compounds that differ from penicillin in having the sulfur of the thiazolidine ring replaced by an oxygen. They have limited antibacterial action, but block bacterial beta-lactamase irreversibly, so that similar antibiotics are not broken down by the bacterial enzymes and therefore can exert their antibacterial effects.
Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses).
Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.
Genes which regulate or circumscribe the activity of other genes; specifically, genes which code for PROTEINS or RNAs which have GENE EXPRESSION REGULATION functions.
Structures within the nucleus of bacterial cells consisting of or containing DNA, which carry genetic information essential to the cell.
Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN.
Substances that reduce the growth or reproduction of BACTERIA.
Antibiotic macrolide produced by Streptomyces antibioticus.
A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc.
Four-membered cyclic AMIDES, best known for the PENICILLINS based on a bicyclo-thiazolidine, as well as the CEPHALOSPORINS based on a bicyclo-thiazine, and including monocyclic MONOBACTAMS. The BETA-LACTAMASES hydrolyze the beta lactam ring, accounting for BETA-LACTAM RESISTANCE of infective bacteria.
Critical and exhaustive investigation or experimentation, having for its aim the discovery of new facts and their correct interpretation, the revision of accepted conclusions, theories, or laws in the light of newly discovered facts, or the practical application of such new or revised conclusions, theories, or laws. (Webster, 3d ed)
An element with atomic symbol Cd, atomic number 48, and atomic weight 114. It is a metal and ingestion will lead to CADMIUM POISONING.
The chemical reactions that occur within the cells, tissues, or an organism. These processes include both the biosynthesis (ANABOLISM) and the breakdown (CATABOLISM) of organic materials utilized by the living organism.
A group of compounds that are derivatives of heptanedioic acid with the general formula R-C7H11O4.
A class of plasmids that transfer antibiotic resistance from one bacterium to another by conjugation.
A fixed-ratio combination of amoxicillin trihydrate and potassium clavulanate.
A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.
Works containing information articles on subjects in every field of knowledge, usually arranged in alphabetical order, or a similar work limited to a special field or subject. (From The ALA Glossary of Library and Information Science, 1983)
The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).
Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration.
Systems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity.
Resistance or diminished response of a neoplasm to an antineoplastic agent in humans, animals, or cell or tissue cultures.

Modified peptidoglycan transpeptidase activity in a carbenicillin-resistant mutant of Pseudomonas aeruginosa 18s. (1/650)

A carbenicillin-resistant mutant of Pseudomonas aeruginosa 18s was found to possess peptidoglycan transpeptidase activity significantly more resistant to inhibition by benzyl penicillin, ampicillin, carbenicillin, and cephaloridine than that of the parent strain. The mutant was more resistant than the parent strain to all of the beta-lactam antibiotics tested, and 50% inhibition values for these compounds against membrane-bound model transpeptidase activity paralleled this increase. The resistance of the mutant to kanamycin, streptomycin, and chloramphenicol was unchanged.  (+info)

Integron- and carbenicillinase-mediated reduced susceptibility to amoxicillin-clavulanic acid in isolates of multidrug-resistant Salmonella enterica serotype typhimurium DT104 from French patients. (2/650)

Fifty-seven Salmonella enterica serotype Typhimurium (S. typhimurium) isolates were collected from human patients in two French hospitals, Hopital Antoine Beclere (Clamart, France) and Hopital Bicetre (Le Kremlin-Bicetre, France), between 1996 and 1997. Thirty of them (52 percent) were resistant to amino-, carbeni-, and ureidopenicillins, had reduced susceptibility to amoxicillin-clavulanic acid, were susceptible to cephalothin, and were resistant to sulfonamides, streptomycin, chloramphenicol, and tetracyclines. All these strains possessed a blaPSE-1-like gene and were of phage type DT104. Ten of them were studied in more detail, which revealed that blaPSE-1 is located on the variable region of a class 1 integron. This integron was found to be chromosomally located, as was another class 1 integron containing aadA2, a streptomycin-spectinomycin resistance gene. The reduced susceptibility to amoxicillin-clavulanic acid (and to ticarcillin-clavulanic acid) may result from the high level of hydrolysis of the beta-lactam rather than to the clavulanic acid resistance properties of PSE-1 in these clonally related S. typhimurium isolates.  (+info)

Clavulanic acid inhibition of beta-lactamase I from Bacillus cereus 569/H. (3/650)

Inactivation of beta-lactamase I by clavulanic acid was investigated. Clavulanic acid induced inhibition of the enzyme was found to be progressive with time. Benzylpenicillin provided protection against the adverse effects of the inhibitor initially, however, the enzyme was irreversibly inhibited in a progressive manner even in the presence of substrate. Reaction of beta-lactamase I with clavulanic acid, in the presence of ampicillin, led to a very rapid inactivation of the enzyme.  (+info)

Variation in the properties of a strain of Staphylococcus aureus isolated over three months from a single hospital. (4/650)

A strain of Staphylococcus aureus has been isolated from a hospital environment over 3 months. Every isolate was lysed by phage 77, had high-level resistance to streptomycin, and was resistant to about 250 pg per ml of both tetracycline and sulphonamide; a combination of sulphamethoxazole and trimethoprim produced little bacteristatic synergy towards each isolate. All These organisms were thus considered to be "the same"; the variation in other properties was probably due to rapid evolutionary change in vivo. the variation in senxitivity to methicillin and neomycin, and the absence of penicillinase production in some isolates, probably indicated loss of the relevant genes. Several isolates had probably acquired resistance to lincomycin by a one-step mutatuon in vivo. The usefulness of lincomycin and analogues in treating staphylococcal infections seems limited.  (+info)

Further evolution of a strain of Staphylococcus aureus in vivo: evidence for significant inactivation of flucloxacillin by penicillinase. (5/650)

A strain of Staphylococcus aureus (no. FAR4) has been isolated at intervals, for 32 months, from the sputum of a patient with cystic fibrosis of the lung. Changes in the properties of isolates of this strain over the first 18 months have been reported previously (Lacey et al., 1973 and 1974). During the last 14 months (May 1973 to July 1974), further evolution has occurred to produce a total of 31 distinct phenotypes. Recent changes are as follows. 1. The ability of isolates to produce penicillinase in vitro was closely correlated with flucloxacillin therapy. Inactivation of flucloxacillin by penicillinase was demonstrated by diffusion testing (but not MIC determination) in vitro and may have occurred to a significant extent in vivo. 2. Lincomycin-resistant mutants slowly disappeared from the sputum after the termination of clindamycin therapy. 3. All of the recent isolates were resistant to erythromycin, possibly because of the linkage of the genes coding for erythromycin resistance with those coding for the production of delta-haemolysin; delta-haemolysin may be an important "virulence factor".  (+info)

PC-904, a novel broad-spectrum semisynthetic penicillin with marked antipseudomonal activity: microbiological evaluation. (6/650)

PC-904, sodium 6-{d(-)-alpha-(4-hydroxy-1,5-naphthyridine-3-carboxamido) phenylacetamido}-penicillanate, is a novel semisynthetic penicillin derivative that possesses a broad spectrum of in vitro and in vivo antibacterial activities. In low concentrations, PC-904 inhibits growth against large proportions of the gram-positive and gram-negative organisms susceptible to carbenicillin and gentamicin. In addition, PC-904 is several times more potent than carbenicillin against organisms such as Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli, Proteus vulgaris, Shigella, Salmonella, Neisseria gonorrhoeae, and Bacteroides fragilis. Most striking are the inhibitory effects of PC-904 against P. aeruginosa and K. pneumoniae. Against these two clinical isolates, PC-904 is, respectively, 35 and 100 times more active than carbenicillin. The minimum inhibitory concentrations of PC-904 against P. aeruginosa are comparable to those of gentamicin. PC-904 acts bactericidally. The effect of inoculum size on the antibacterial activity is often small and generally comparable to carbenicillin. The rate of binding to serum protein is high (88 to 98%), but the effect of the addition of serum on the drug's activity is not marked, because such binding is reversible. It is confirmed that PC-904 has a very potent in vivo antibacterial activity against gram-negative and gram-positive organisms. Against systemic infections with P. aeruginosa, K. pneumoniae, and E. coli in mice, PC-904 is 7 to 10 times, over 8 times, and 2 to 15 times more active than carbenicillin, respectively.  (+info)

Genetic and molecular characterisation of resistance determinants in methicillin-resistant Staphylococcus-aureus. (7/650)

A genetic analysis of resistance to antibiotics in methicillin-resistant Staphylococcus aureus was performed. Demonstration of plasmid-specific DNA either in transductants that had received antibiotic-resistance markers from multiply-resistant strains, or in segregants of methicillin-resistant strains that had lost unstable determinants except the one under study, indicated that markers of resistance to penicillin, chloramphenicol and neomycin are present on separate, mutually compatible plasmids. Absence of covalently closed circular DNA was demonstrated in transductants that were resistant to methicillin, tetracycline, erythromycin and streptomycin, as well as in segregants that had lost the penicillinase, chloramphenicol and neomycin plasmid, but were still resistant to methicillin, tetracycline, erythromycin, streptomycin and the sulphonamides. Analysis of plasmid DNA either in a 5-20% neutral sucrose gradient or by electron microscopy revealed the presence of three readily distinguishable plasmids. The molecular weights of these plasmids were estimated by comparing the sedimentation rate constants with those of known reference plasmids and by contour-length measurements. The molecular weight of the penicillinase plasmid was estimated to be 20 X 10(6) daltons, that of the chloramphenicol plasmid 3 X 10(6) daltons and that of the plasmid carrying the neomycin resistance marker 37 X 10(6) daltons.  (+info)

Inducible oxacillin-hydrolyzing penicillinase in Aeromonas hydrophila isolated from fish. (8/650)

An inducible penicillinase was shown to be present in a strain of Aeromonas hydrophila subsp. hydrophila isolated from freshwater fish. Enzyme induction was observed with benzylpenicillin or 6-aminopenicillanic acid, and the enzyme was cell bound. The penicillinase was purified 50-fold from a crude cell extract. The molecular weight was estimated to be 23,000 by gel filtration. The pH and temperature optima for the enzyme activity were 8.0 and 35 degrees C, respectively. The penicillinase showed a unique substrate profile by hydrolyzing oxacillin about twice as rapidly as benzylpenicillin. The enzyme activity was weakly inhibited by sodium chloride but was not affected by p-chloromercuribenzoate. The property of penicillinase production by the A. hydrophila strain could not be transferred to Escherichia coli and also could not be eliminated from the bacteria by ethidium bromide treatment.  (+info)

Penicillinase is an enzyme produced by some bacteria that can inactivate penicillin and other beta-lactam antibiotics by breaking down the beta-lactam ring, which is essential for their antimicrobial activity. Bacteria that produce penicillinase are resistant to penicillin and related antibiotics. Penicillinase-resistant penicillins, such as methicillin and oxacillin, have been developed to overcome this form of bacterial resistance.

Penicillin G is a type of antibiotic that belongs to the class of medications called penicillins. It is a natural antibiotic derived from the Penicillium fungus and is commonly used to treat a variety of bacterial infections. Penicillin G is active against many gram-positive bacteria, as well as some gram-negative bacteria.

Penicillin G is available in various forms, including an injectable solution and a powder for reconstitution into a solution. It works by interfering with the ability of bacteria to form a cell wall, which ultimately leads to bacterial death. Penicillin G is often used to treat serious infections that cannot be treated with other antibiotics, such as endocarditis (inflammation of the inner lining of the heart), pneumonia, and meningitis (inflammation of the membranes surrounding the brain and spinal cord).

It's important to note that Penicillin G is not commonly used for topical or oral treatment due to its poor absorption in the gastrointestinal tract and instability in acidic environments. Additionally, as with all antibiotics, Penicillin G should be used under the guidance of a healthcare professional to ensure appropriate use and to reduce the risk of antibiotic resistance.

Staphylococcus is a genus of Gram-positive, facultatively anaerobic bacteria that are commonly found on the skin and mucous membranes of humans and other animals. Many species of Staphylococcus can cause infections in humans, but the most notable is Staphylococcus aureus, which is responsible for a wide range of illnesses, from minor skin infections to life-threatening conditions such as pneumonia, endocarditis, and sepsis.

Staphylococcus species are non-motile, non-spore forming, and typically occur in grape-like clusters when viewed under a microscope. They can be coagulase-positive or coagulase-negative, with S. aureus being the most well-known coagulase-positive species. Coagulase is an enzyme that causes the clotting of plasma, and its presence is often used to differentiate S. aureus from other Staphylococcus species.

These bacteria are resistant to many commonly used antibiotics, including penicillin, due to the production of beta-lactamases. Methicillin-resistant Staphylococcus aureus (MRSA) is a particularly problematic strain that has developed resistance to multiple antibiotics and can cause severe, difficult-to-treat infections.

Proper hand hygiene, use of personal protective equipment, and environmental cleaning are crucial measures for preventing the spread of Staphylococcus in healthcare settings and the community.

'Bacillus' is a genus of rod-shaped, gram-positive bacteria that are commonly found in soil, water, and the gastrointestinal tracts of animals. Many species of Bacillus are capable of forming endospores, which are highly resistant to heat, radiation, and chemicals, allowing them to survive for long periods in harsh environments. The most well-known species of Bacillus is B. anthracis, which causes anthrax in animals and humans. Other species of Bacillus have industrial or agricultural importance, such as B. subtilis, which is used in the production of enzymes and antibiotics.

Penicillin resistance is the ability of certain bacteria to withstand the antibacterial effects of penicillin, a type of antibiotic. This occurs when these bacteria have developed mechanisms that prevent penicillin from binding to and inhibiting the function of their cell wall biosynthesis proteins, particularly the enzyme transpeptidase.

One common mechanism of penicillin resistance is the production of beta-lactamases, enzymes that can hydrolyze and inactivate the beta-lactam ring structure present in penicillin and other related antibiotics. Another mechanism involves alterations in the bacterial cell wall that prevent penicillin from binding to its target proteins.

Penicillin resistance is a significant concern in clinical settings, as it can limit treatment options for bacterial infections and may necessitate the use of more potent or toxic antibiotics. It is important to note that misuse or overuse of antibiotics can contribute to the development and spread of antibiotic-resistant bacteria, including those resistant to penicillin.

Penicillins are a group of antibiotics derived from the Penicillium fungus. They are widely used to treat various bacterial infections due to their bactericidal activity, which means they kill bacteria by interfering with the synthesis of their cell walls. The first penicillin, benzylpenicillin (also known as penicillin G), was discovered in 1928 by Sir Alexander Fleming. Since then, numerous semi-synthetic penicillins have been developed to expand the spectrum of activity and stability against bacterial enzymes that can inactivate these drugs.

Penicillins are classified into several groups based on their chemical structure and spectrum of activity:

1. Natural Penicillins (e.g., benzylpenicillin, phenoxymethylpenicillin): These have a narrow spectrum of activity, mainly targeting Gram-positive bacteria such as streptococci and staphylococci. However, they are susceptible to degradation by beta-lactamase enzymes produced by some bacteria.
2. Penicillinase-resistant Penicillins (e.g., methicillin, oxacillin, nafcillin): These penicillins resist degradation by certain bacterial beta-lactamases and are primarily used to treat infections caused by staphylococci, including methicillin-susceptible Staphylococcus aureus (MSSA).
3. Aminopenicillins (e.g., ampicillin, amoxicillin): These penicillins have an extended spectrum of activity compared to natural penicillins, including some Gram-negative bacteria such as Escherichia coli and Haemophilus influenzae. However, they are still susceptible to degradation by many beta-lactamases.
4. Antipseudomonal Penicillins (e.g., carbenicillin, ticarcillin): These penicillins have activity against Pseudomonas aeruginosa and other Gram-negative bacteria with increased resistance to other antibiotics. They are often combined with beta-lactamase inhibitors such as clavulanate or tazobactam to protect them from degradation.
5. Extended-spectrum Penicillins (e.g., piperacillin): These penicillins have a broad spectrum of activity, including many Gram-positive and Gram-negative bacteria. They are often combined with beta-lactamase inhibitors to protect them from degradation.

Penicillins are generally well-tolerated antibiotics; however, they can cause allergic reactions in some individuals, ranging from mild skin rashes to life-threatening anaphylaxis. Cross-reactivity between different penicillin classes and other beta-lactam antibiotics (e.g., cephalosporins) is possible but varies depending on the specific drugs involved.

Staphylococcus phages do not have a specific medical definition, but I can provide you with some information about both concepts:

1. Staphylococcus: This term refers to a group of bacteria that can cause various infections in humans and animals. The most common species is Staphylococcus aureus, which often colonizes the skin and nasal passages of healthy individuals. However, it can lead to infections when it enters the body through wounds or other breaks in the skin.

2. Phages: These are viruses that infect and kill bacteria. They specifically target and replicate within bacterial cells, using the host's machinery for their reproduction. Once the phage has multiplied sufficiently, it causes the bacterial cell to lyse (burst), releasing new phage particles into the environment. Phages can be specific to certain bacterial species or strains, making them potential alternatives to antibiotics in treating bacterial infections without disrupting the normal microbiota.

When combining these two concepts, Staphylococcus phages refer to viruses that infect and kill Staphylococcus bacteria. These phages can be used as therapeutic agents to treat Staphylococcus infections, particularly those caused by antibiotic-resistant strains like methicillin-resistant Staphylococcus aureus (MRSA). However, it is essential to note that the use of phages as a treatment option is still an experimental approach and requires further research before becoming a widely accepted therapeutic strategy.

Neisseria gonorrhoeae is a species of gram-negative, aerobic diplococcus that is the etiologic agent of gonorrhea, a sexually transmitted infection. It is commonly found in the mucous membranes of the reproductive tract, including the cervix, urethra, and rectum, as well as the throat and eyes. The bacterium can cause a range of symptoms, including discharge, burning during urination, and, in women, abnormal menstrual bleeding. If left untreated, it can lead to more serious complications, such as pelvic inflammatory disease and infertility. It is important to note that N. gonorrhoeae has developed resistance to many antibiotics over time, making treatment more challenging. A culture or nucleic acid amplification test (NAAT) is used for the diagnosis of this infection.

Extrachromosomal inheritance refers to the transmission of genetic information that occurs outside of the chromosomes, which are the structures in the cell nucleus that typically contain and transmit genetic material. This type of inheritance is relatively rare and can involve various types of genetic elements, such as plasmids or transposons.

In extrachromosomal inheritance, these genetic elements can replicate independently of the chromosomes and be passed on to offspring through mechanisms other than traditional Mendelian inheritance. This can lead to non-Mendelian patterns of inheritance, where traits do not follow the expected dominant or recessive patterns.

One example of extrachromosomal inheritance is the transmission of mitochondrial DNA (mtDNA), which occurs in the cytoplasm of the cell rather than on the chromosomes. Mitochondria are organelles that produce energy for the cell, and they contain their own small circular genome that is inherited maternally. Mutations in mtDNA can lead to a variety of genetic disorders, including mitochondrial diseases.

Overall, extrachromosomal inheritance is an important area of study in genetics, as it can help researchers better understand the complex ways in which genetic information is transmitted and expressed in living organisms.

Cephaloridine is a type of antibiotic that belongs to the class of cephalosporins. It is used for treating various bacterial infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, bone and joint infections, and septicemia.

Cephaloridine works by inhibiting the synthesis of the bacterial cell wall, leading to bacterial death. It is administered intramuscularly or intravenously and is known for its broad-spectrum activity against both Gram-positive and Gram-negative bacteria. However, due to its potential nephrotoxicity (kidney toxicity), it has largely been replaced by other antibiotics with similar spectra of activity but better safety profiles.

It's important to note that the use of cephaloridine should be reserved for infections caused by bacteria that are resistant to other antibiotics, and its administration should be closely monitored by a healthcare professional to minimize the risk of adverse effects.

Microbial genetics is the study of heredity and variation in microorganisms, including bacteria, viruses, fungi, and parasites. It involves the investigation of their genetic material (DNA and RNA), genes, gene expression, genetic regulation, mutations, genetic recombination, and genome organization. This field is crucial for understanding the mechanisms of microbial pathogenesis, evolution, ecology, and biotechnological applications. Research in microbial genetics has led to significant advancements in areas such as antibiotic resistance, vaccine development, and gene therapy.

Gonorrhea is a sexually transmitted infection (STI) caused by the bacterium Neisseria gonorrhoeae, also known as "gono" bacteria. It can infect various parts of the body including the genitals, rectum, and throat. The bacteria are typically transmitted through sexual contact with an infected person.

Symptoms may vary but often include abnormal discharge from the genitals or rectum, painful or burning sensations during urination, and in women, vaginal bleeding between periods. However, many people with gonorrhea do not develop symptoms, making it essential to get tested regularly if you are sexually active with multiple partners or have unprotected sex.

If left untreated, gonorrhea can lead to severe complications such as pelvic inflammatory disease (PID) in women and epididymitis in men, which may result in infertility. In rare cases, it can spread to the bloodstream and cause life-threatening conditions like sepsis.

Gonorrhea is curable with appropriate antibiotic treatment; however, drug-resistant strains of the bacteria have emerged, making accurate diagnosis and effective treatment increasingly challenging. Prevention methods include using condoms during sexual activity and practicing safe sex habits.

'Bacillus cereus' is a gram-positive, rod-shaped bacterium that is commonly found in soil and food. It can produce heat-resistant spores, which allow it to survive in a wide range of temperatures and environments. This bacterium can cause two types of foodborne illnesses: a diarrheal type and an emetic (vomiting) type.

The diarrheal type of illness is caused by the consumption of foods contaminated with large numbers of vegetative cells of B. cereus. The symptoms typically appear within 6 to 15 hours after ingestion and include watery diarrhea, abdominal cramps, and nausea. Vomiting may also occur in some cases.

The emetic type of illness is caused by the consumption of foods contaminated with B. cereus toxins. This type of illness is characterized by nausea and vomiting that usually occur within 0.5 to 6 hours after ingestion. The most common sources of B. cereus contamination include rice, pasta, and other starchy foods that have been cooked and left at room temperature for several hours.

Proper food handling, storage, and cooking practices can help prevent B. cereus infections. It is important to refrigerate or freeze cooked foods promptly, reheat them thoroughly, and avoid leaving them at room temperature for extended periods.

A protoplast is not a term that is typically used in medical definitions, but rather it is a term commonly used in cell biology and botany. A protoplast refers to a plant or bacterial cell that has had its cell wall removed, leaving only the plasma membrane and the cytoplasmic contents, including organelles such as mitochondria, chloroplasts, ribosomes, and other cellular structures.

Protoplasts can be created through enzymatic or mechanical means to isolate the intracellular components for various research purposes, such as studying membrane transport, gene transfer, or cell fusion. In some cases, protoplasts may be used in medical research, particularly in areas related to plant pathology and genetic engineering of plants for medical applications.

Cloxacillin is a type of antibiotic known as a penicillinase-resistant penicillin. It is used to treat infections caused by bacteria that are resistant to other types of penicillins. Cloxacillin works by interfering with the ability of the bacterial cell wall to grow and multiply, ultimately leading to the death of the bacterium.

Cloxacillin is often used to treat skin infections, pneumonia, and other respiratory tract infections. It is available in various forms, including tablets, capsules, and powder for injection. As with all antibiotics, it is important to take cloxacillin exactly as directed by a healthcare provider, and to complete the full course of treatment, even if symptoms improve before all of the medication has been taken.

Like other penicillins, cloxacillin can cause allergic reactions in some people. It may also interact with other medications, so it is important to inform a healthcare provider of all other medications being taken before starting cloxacillin.

Beta-lactamases are enzymes produced by certain bacteria that can break down and inactivate beta-lactam antibiotics, such as penicillins, cephalosporins, and carbapenems. This enzymatic activity makes the bacteria resistant to these antibiotics, limiting their effectiveness in treating infections caused by these organisms.

Beta-lactamases work by hydrolyzing the beta-lactam ring, a structural component of these antibiotics that is essential for their antimicrobial activity. By breaking down this ring, the enzyme renders the antibiotic ineffective against the bacterium, allowing it to continue growing and potentially causing harm.

There are different classes of beta-lactamases (e.g., Ambler Class A, B, C, and D), each with distinct characteristics and mechanisms for breaking down various beta-lactam antibiotics. The emergence and spread of bacteria producing these enzymes have contributed to the growing problem of antibiotic resistance, making it increasingly challenging to treat infections caused by these organisms.

To overcome this issue, researchers have developed beta-lactamase inhibitors, which are drugs that can bind to and inhibit the activity of these enzymes, thus restoring the effectiveness of certain beta-lactam antibiotics. Examples of such combinations include amoxicillin/clavulanate (Augmentin) and piperacillin/tazobactam (Zosyn).

Ampicillin is a penicillin-type antibiotic used to treat a wide range of bacterial infections. It works by interfering with the ability of bacteria to form cell walls, which are essential for their survival. This causes the bacterial cells to become unstable and eventually die.

The medical definition of Ampicillin is:

"A semi-synthetic penicillin antibiotic, derived from the Penicillium mold. It is used to treat a variety of infections caused by susceptible gram-positive and gram-negative bacteria. Ampicillin is effective against both aerobic and anaerobic organisms. It is commonly used to treat respiratory tract infections, urinary tract infections, meningitis, and endocarditis."

It's important to note that Ampicillin is not effective against infections caused by methicillin-resistant Staphylococcus aureus (MRSA) or other bacteria that have developed resistance to penicillins. Additionally, overuse of antibiotics like Ampicillin can lead to the development of antibiotic resistance, which is a significant public health concern.

Methicillin is defined as a narrow-spectrum antibiotic that belongs to the penicillin class. It was initially developed to address the problem of beta-lactamase enzyme production in Staphylococcus aureus bacteria, which made them resistant to earlier penicillins. However, methicillin-resistant strains of S. aureus (MRSA) have since emerged and become a significant global health concern. Methicillin is no longer used clinically due to its high nephrotoxicity, but the term "methicillin-resistant" remains relevant in describing resistant bacteria.

Enzyme induction is a process by which the activity or expression of an enzyme is increased in response to some stimulus, such as a drug, hormone, or other environmental factor. This can occur through several mechanisms, including increasing the transcription of the enzyme's gene, stabilizing the mRNA that encodes the enzyme, or increasing the translation of the mRNA into protein.

In some cases, enzyme induction can be a beneficial process, such as when it helps the body to metabolize and clear drugs more quickly. However, in other cases, enzyme induction can have negative consequences, such as when it leads to the increased metabolism of important endogenous compounds or the activation of harmful procarcinogens.

Enzyme induction is an important concept in pharmacology and toxicology, as it can affect the efficacy and safety of drugs and other xenobiotics. It is also relevant to the study of drug interactions, as the induction of one enzyme by a drug can lead to altered metabolism and effects of another drug that is metabolized by the same enzyme.

Spectinomycin is an antibiotic that belongs to the aminoglycoside family. It works by binding to the 30S subunit of the bacterial ribosome, thereby inhibiting protein synthesis and leading to bacterial cell death. Spectinomycin is primarily used to treat infections caused by susceptible strains of Gram-negative and Gram-positive bacteria, including gonorrhea, penicillin-resistant streptococci, and some anaerobes. It is administered parenterally (usually intramuscularly) and has a relatively narrow spectrum of activity compared to other aminoglycosides. Spectinomycin is not commonly used in many countries due to the availability of alternative antibiotics with broader spectra and fewer side effects.

Penicillanic acid is not a term that has a widely accepted or established medical definition in the context of human medicine or clinical practice. It is a chemical compound that is a derivative of penicillin, an antibiotic produced by certain types of mold. Penicillanic acid is a breakdown product of penicillin and is not itself used as a medication.

In chemistry, penicillanic acid is a organic compound with the formula (CH3)2C6H5COOH. It is a derivative of benzene and has a carboxylic acid group and a five-membered ring containing a sulfur atom and a double bond, which is a characteristic feature of penicillin and its derivatives.

It's important to note that while penicillanic acid may have relevance in the context of chemistry or microbiology research, it does not have a direct medical definition or application in clinical medicine.

Pharmacology is the branch of medicine and biology concerned with the study of drugs, their actions, and their uses. It involves understanding how drugs interact with biological systems to produce desired effects, as well as any adverse or unwanted effects. This includes studying the absorption, distribution, metabolism, and excretion of drugs (often referred to as ADME), the receptors and biochemical pathways that drugs affect, and the therapeutic benefits and risks of drug use. Pharmacologists may also be involved in the development and testing of new medications.

A cephalosporinase is an enzyme that can break down and inactivate cephalosporins, a group of antibiotics commonly used to treat various bacterial infections. Bacteria that produce this enzyme are referred to as "cephalosporin-resistant" or "cephalosporinase-producing" organisms. The production of cephalosporinases by bacteria can lead to treatment failures and make infections more difficult to manage.

Cephalosporins are broad-spectrum antibiotics, which means they can be effective against a wide range of bacterial species. However, some bacteria have developed resistance mechanisms, such as the production of cephalosporinases, to counteract their effects. These enzymes hydrolyze the beta-lactam ring in cephalosporins, rendering them ineffective.

There are different classes of cephalosporinases (e.g., Ambler classes A, C, and D), each with distinct characteristics and substrate profiles. Some cephalosporinases can hydrolyze a broader range of cephalosporins than others, leading to varying degrees of resistance.

To overcome cephalosporinase-mediated resistance, alternative antibiotics or combinations of antibiotics may be used. Additionally, the development of new cephalosporins with improved stability against these enzymes is an ongoing area of research in the field of antimicrobial drug discovery.

In the context of medicine, Mercury does not have a specific medical definition. However, it may refer to:

1. A heavy, silvery-white metal that is liquid at room temperature. It has been used in various medical and dental applications, such as therapeutic remedies (now largely discontinued) and dental amalgam fillings. Its use in dental fillings has become controversial due to concerns about its potential toxicity.
2. In microbiology, Mercury is the name of a bacterial genus that includes the pathogenic species Mercury deserti and Mercury avium. These bacteria can cause infections in humans and animals.

It's important to note that when referring to the planet or the use of mercury in astrology, these are not related to medical definitions.

Tetracycline is a broad-spectrum antibiotic, which is used to treat various bacterial infections. It works by preventing the growth and multiplication of bacteria. It is a part of the tetracycline class of antibiotics, which also includes doxycycline, minocycline, and others.

Tetracycline is effective against a wide range of gram-positive and gram-negative bacteria, as well as some atypical organisms such as rickettsia, chlamydia, mycoplasma, and spirochetes. It is commonly used to treat respiratory infections, skin infections, urinary tract infections, sexually transmitted diseases, and other bacterial infections.

Tetracycline is available in various forms, including tablets, capsules, and liquid solutions. It should be taken orally with a full glass of water, and it is recommended to take it on an empty stomach, at least one hour before or two hours after meals. The drug can cause tooth discoloration in children under the age of 8, so it is generally not recommended for use in this population.

Like all antibiotics, tetracycline should be used only to treat bacterial infections and not viral infections, such as the common cold or flu. Overuse or misuse of antibiotics can lead to antibiotic resistance, which makes it harder to treat infections in the future.

Azaguanine is a type of antimetabolite drug that is used in medical research and treatment. It is a purine analogue, which means it has a similar chemical structure to the natural purine bases adenine and guanine, which are building blocks of DNA and RNA. Azaguanine can be incorporated into the genetic material of cells, interfering with their normal function and replication. It is used in research to study the effects of such interference on cell growth and development.

In clinical medicine, azaguanine has been used as an anticancer drug, although it is not widely used today due to its toxicity and the availability of more effective treatments. It may also have some activity against certain types of parasitic infections, such as leishmaniasis and malaria.

It's important to note that azaguanine is not a commonly used medication and its use should be under the supervision of a medical professional with experience in its administration and management of potential side effects.

Oxacillin is a type of antibiotic known as a penicillinase-resistant penicillin. It is used to treat infections caused by bacteria that are resistant to other types of penicillins. Oxacillin is commonly used to treat infections of the skin, soft tissue, and bone.

Here is the medical definition of oxacillin:

Oxacillin is a semisynthetic antibiotic derived from penicillin that is resistant to staphylococcal penicillinases. It is used to treat infections caused by susceptible strains of staphylococci and some streptococci, including penicillinase-producing staphylococci. Oxacillin is available as a sterile powder for injection or as a oral capsule.

It is important to note that the overuse or misuse of antibiotics like oxacillin can lead to the development of antibiotic resistance, which makes infections harder to treat. It's essential to use antibiotics only when necessary and as directed by a healthcare professional.

Cephalosporins are a class of antibiotics that are derived from the fungus Acremonium, originally isolated from seawater and cow dung. They have a similar chemical structure to penicillin and share a common four-membered beta-lactam ring in their molecular structure.

Cephalosporins work by inhibiting the synthesis of bacterial cell walls, which ultimately leads to bacterial death. They are broad-spectrum antibiotics, meaning they are effective against a wide range of bacteria, including both Gram-positive and Gram-negative organisms.

There are several generations of cephalosporins, each with different spectra of activity and pharmacokinetic properties. The first generation cephalosporins have a narrow spectrum of activity and are primarily used to treat infections caused by susceptible Gram-positive bacteria, such as Staphylococcus aureus and Streptococcus pneumoniae.

Second-generation cephalosporins have an expanded spectrum of activity that includes some Gram-negative organisms, such as Escherichia coli and Haemophilus influenzae. Third-generation cephalosporins have even broader spectra of activity and are effective against many resistant Gram-negative bacteria, such as Pseudomonas aeruginosa and Klebsiella pneumoniae.

Fourth-generation cephalosporins have activity against both Gram-positive and Gram-negative organisms, including some that are resistant to other antibiotics. They are often reserved for the treatment of serious infections caused by multidrug-resistant bacteria.

Cephalosporins are generally well tolerated, but like penicillin, they can cause allergic reactions in some individuals. Cross-reactivity between cephalosporins and penicillin is estimated to occur in 5-10% of patients with a history of penicillin allergy. Other potential adverse effects include gastrointestinal symptoms (such as nausea, vomiting, and diarrhea), neurotoxicity, and nephrotoxicity.

Microbial drug resistance is a significant medical issue that refers to the ability of microorganisms (such as bacteria, viruses, fungi, or parasites) to withstand or survive exposure to drugs or medications designed to kill them or limit their growth. This phenomenon has become a major global health concern, particularly in the context of bacterial infections, where it is also known as antibiotic resistance.

Drug resistance arises due to genetic changes in microorganisms that enable them to modify or bypass the effects of antimicrobial agents. These genetic alterations can be caused by mutations or the acquisition of resistance genes through horizontal gene transfer. The resistant microbes then replicate and multiply, forming populations that are increasingly difficult to eradicate with conventional treatments.

The consequences of drug-resistant infections include increased morbidity, mortality, healthcare costs, and the potential for widespread outbreaks. Factors contributing to the emergence and spread of microbial drug resistance include the overuse or misuse of antimicrobials, poor infection control practices, and inadequate surveillance systems.

To address this challenge, it is crucial to promote prudent antibiotic use, strengthen infection prevention and control measures, develop new antimicrobial agents, and invest in research to better understand the mechanisms underlying drug resistance.

A plasmid is a small, circular, double-stranded DNA molecule that is separate from the chromosomal DNA of a bacterium or other organism. Plasmids are typically not essential for the survival of the organism, but they can confer beneficial traits such as antibiotic resistance or the ability to degrade certain types of pollutants.

Plasmids are capable of replicating independently of the chromosomal DNA and can be transferred between bacteria through a process called conjugation. They often contain genes that provide resistance to antibiotics, heavy metals, and other environmental stressors. Plasmids have also been engineered for use in molecular biology as cloning vectors, allowing scientists to replicate and manipulate specific DNA sequences.

Plasmids are important tools in genetic engineering and biotechnology because they can be easily manipulated and transferred between organisms. They have been used to produce vaccines, diagnostic tests, and genetically modified organisms (GMOs) for various applications, including agriculture, medicine, and industry.

Genetic transduction is a process in molecular biology that describes the transfer of genetic material from one bacterium to another by a viral vector called a bacteriophage (or phage). In this process, the phage infects one bacterium and incorporates a portion of the bacterial DNA into its own genetic material. When the phage then infects a second bacterium, it can transfer the incorporated bacterial DNA to the new host. This can result in the horizontal gene transfer (HGT) of traits such as antibiotic resistance or virulence factors between bacteria.

There are two main types of transduction: generalized and specialized. In generalized transduction, any portion of the bacterial genome can be packaged into the phage particle, leading to a random assortment of genetic material being transferred. In specialized transduction, only specific genes near the site where the phage integrates into the bacterial chromosome are consistently transferred.

It's important to note that genetic transduction is not to be confused with transformation or conjugation, which are other mechanisms of HGT in bacteria.

Clavulanic acid is not a medical condition, but rather an antibacterial compound that is often combined with certain antibiotics to increase their effectiveness against bacteria that have become resistant to the antibiotic alone. It works by inhibiting certain enzymes produced by bacteria that help them to resist the antibiotic, allowing the antibiotic to work more effectively.

Clavulanic acid is typically combined with antibiotics such as amoxicillin or ticarcillin to treat a variety of bacterial infections, including respiratory tract infections, urinary tract infections, and skin and soft tissue infections. It is important to note that clavulanate-containing medications should only be used under the direction of a healthcare provider, as misuse or overuse can contribute to antibiotic resistance.

Microbial sensitivity tests, also known as antibiotic susceptibility tests (ASTs) or bacterial susceptibility tests, are laboratory procedures used to determine the effectiveness of various antimicrobial agents against specific microorganisms isolated from a patient's infection. These tests help healthcare providers identify which antibiotics will be most effective in treating an infection and which ones should be avoided due to resistance. The results of these tests can guide appropriate antibiotic therapy, minimize the potential for antibiotic resistance, improve clinical outcomes, and reduce unnecessary side effects or toxicity from ineffective antimicrobials.

There are several methods for performing microbial sensitivity tests, including:

1. Disk diffusion method (Kirby-Bauer test): A standardized paper disk containing a predetermined amount of an antibiotic is placed on an agar plate that has been inoculated with the isolated microorganism. After incubation, the zone of inhibition around the disk is measured to determine the susceptibility or resistance of the organism to that particular antibiotic.
2. Broth dilution method: A series of tubes or wells containing decreasing concentrations of an antimicrobial agent are inoculated with a standardized microbial suspension. After incubation, the minimum inhibitory concentration (MIC) is determined by observing the lowest concentration of the antibiotic that prevents visible growth of the organism.
3. Automated systems: These use sophisticated technology to perform both disk diffusion and broth dilution methods automatically, providing rapid and accurate results for a wide range of microorganisms and antimicrobial agents.

The interpretation of microbial sensitivity test results should be done cautiously, considering factors such as the site of infection, pharmacokinetics and pharmacodynamics of the antibiotic, potential toxicity, and local resistance patterns. Regular monitoring of susceptibility patterns and ongoing antimicrobial stewardship programs are essential to ensure optimal use of these tests and to minimize the development of antibiotic resistance.

Staphylococcus aureus is a type of gram-positive, round (coccal) bacterium that is commonly found on the skin and mucous membranes of warm-blooded animals and humans. It is a facultative anaerobe, which means it can grow in the presence or absence of oxygen.

Staphylococcus aureus is known to cause a wide range of infections, from mild skin infections such as pimples, impetigo, and furuncles (boils) to more severe and potentially life-threatening infections such as pneumonia, endocarditis, osteomyelitis, and sepsis. It can also cause food poisoning and toxic shock syndrome.

The bacterium is often resistant to multiple antibiotics, including methicillin, which has led to the emergence of methicillin-resistant Staphylococcus aureus (MRSA) strains that are difficult to treat. Proper hand hygiene and infection control practices are critical in preventing the spread of Staphylococcus aureus and MRSA.

Regulator genes are a type of gene that regulates the activity of other genes in an organism. They do not code for a specific protein product but instead control the expression of other genes by producing regulatory proteins such as transcription factors, repressors, or enhancers. These regulatory proteins bind to specific DNA sequences near the target genes and either promote or inhibit their transcription into mRNA. This allows regulator genes to play a crucial role in coordinating complex biological processes, including development, differentiation, metabolism, and response to environmental stimuli.

There are several types of regulator genes, including:

1. Constitutive regulators: These genes are always active and produce regulatory proteins that control the expression of other genes in a consistent manner.
2. Inducible regulators: These genes respond to specific signals or environmental stimuli by producing regulatory proteins that modulate the expression of target genes.
3. Negative regulators: These genes produce repressor proteins that bind to DNA and inhibit the transcription of target genes, thereby reducing their expression.
4. Positive regulators: These genes produce activator proteins that bind to DNA and promote the transcription of target genes, thereby increasing their expression.
5. Master regulators: These genes control the expression of multiple downstream target genes involved in specific biological processes or developmental pathways.

Regulator genes are essential for maintaining proper gene expression patterns and ensuring normal cellular function. Mutations in regulator genes can lead to various diseases, including cancer, developmental disorders, and metabolic dysfunctions.

Bacterial chromosomes are typically circular, double-stranded DNA molecules that contain the genetic material of bacteria. Unlike eukaryotic cells, which have their DNA housed within a nucleus, bacterial chromosomes are located in the cytoplasm of the cell, often associated with the bacterial nucleoid.

Bacterial chromosomes can vary in size and structure among different species, but they typically contain all of the genetic information necessary for the survival and reproduction of the organism. They may also contain plasmids, which are smaller circular DNA molecules that can carry additional genes and can be transferred between bacteria through a process called conjugation.

One important feature of bacterial chromosomes is their ability to replicate rapidly, allowing bacteria to divide quickly and reproduce in large numbers. The replication of the bacterial chromosome begins at a specific origin point and proceeds in opposite directions until the entire chromosome has been copied. This process is tightly regulated and coordinated with cell division to ensure that each daughter cell receives a complete copy of the genetic material.

Overall, the study of bacterial chromosomes is an important area of research in microbiology, as understanding their structure and function can provide insights into bacterial genetics, evolution, and pathogenesis.

Culture media is a substance that is used to support the growth of microorganisms or cells in an artificial environment, such as a petri dish or test tube. It typically contains nutrients and other factors that are necessary for the growth and survival of the organisms being cultured. There are many different types of culture media, each with its own specific formulation and intended use. Some common examples include blood agar, which is used to culture bacteria; Sabouraud dextrose agar, which is used to culture fungi; and Eagle's minimum essential medium, which is used to culture animal cells.

Anti-bacterial agents, also known as antibiotics, are a type of medication used to treat infections caused by bacteria. These agents work by either killing the bacteria or inhibiting their growth and reproduction. There are several different classes of anti-bacterial agents, including penicillins, cephalosporins, fluoroquinolones, macrolides, and tetracyclines, among others. Each class of antibiotic has a specific mechanism of action and is used to treat certain types of bacterial infections. It's important to note that anti-bacterial agents are not effective against viral infections, such as the common cold or flu. Misuse and overuse of antibiotics can lead to antibiotic resistance, which is a significant global health concern.

Oleandomycin is an antibiotic that belongs to the class of macrolides. It is primarily used in veterinary medicine for treating bacterial infections in animals. The drug works by inhibiting protein synthesis in bacteria, which interferes with their growth and multiplication. Oleandomycin is not commonly used in human medicine due to its potential for causing liver toxicity.

Here's a more detailed medical definition of Oleandomycin:

Oleandomycin is a macrolide antibiotic derived from Streptomyces antibioticus. It has a molecular formula of C32H47NO13 and a molecular weight of 659.7 g/mol. The drug is administered orally and has a broad spectrum of activity against gram-positive bacteria, including streptococci, staphylococci, and pneumococci. Oleandomycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, which interferes with peptide bond formation.

While oleandomycin has been used in human medicine in the past, it is not commonly used today due to its potential for causing liver toxicity. It is primarily used in veterinary medicine for treating bacterial infections in animals. Oleandomycin may be used as an alternative antibiotic in cases where other macrolides are not effective or well-tolerated.

It's important to note that the use of any antibiotics, including oleandomycin, should be done under the guidance and supervision of a licensed healthcare provider. Misuse or overuse of antibiotics can lead to antibiotic resistance, which is a significant public health concern.

'Escherichia coli' (E. coli) is a type of gram-negative, facultatively anaerobic, rod-shaped bacterium that commonly inhabits the intestinal tract of humans and warm-blooded animals. It is a member of the family Enterobacteriaceae and one of the most well-studied prokaryotic model organisms in molecular biology.

While most E. coli strains are harmless and even beneficial to their hosts, some serotypes can cause various forms of gastrointestinal and extraintestinal illnesses in humans and animals. These pathogenic strains possess virulence factors that enable them to colonize and damage host tissues, leading to diseases such as diarrhea, urinary tract infections, pneumonia, and sepsis.

E. coli is a versatile organism with remarkable genetic diversity, which allows it to adapt to various environmental niches. It can be found in water, soil, food, and various man-made environments, making it an essential indicator of fecal contamination and a common cause of foodborne illnesses. The study of E. coli has contributed significantly to our understanding of fundamental biological processes, including DNA replication, gene regulation, and protein synthesis.

Beta-lactams are a class of antibiotics that include penicillins, cephalosporins, carbapenems, and monobactams. They contain a beta-lactam ring in their chemical structure, which is responsible for their antibacterial activity. The beta-lactam ring inhibits the bacterial enzymes necessary for cell wall synthesis, leading to bacterial death. Beta-lactams are commonly used to treat a wide range of bacterial infections, including respiratory tract infections, skin and soft tissue infections, urinary tract infections, and bone and joint infections. However, some bacteria have developed resistance to beta-lactams through the production of beta-lactamases, enzymes that can break down the beta-lactam ring and render the antibiotic ineffective. To overcome this resistance, beta-lactam antibiotics are often combined with beta-lactamase inhibitors, which protect the beta-lactam ring from degradation.

Research, in the context of medicine, is a systematic and rigorous process of collecting, analyzing, and interpreting information in order to increase our understanding, develop new knowledge, or evaluate current practices and interventions. It can involve various methodologies such as observational studies, experiments, surveys, or literature reviews. The goal of medical research is to advance health care by identifying new treatments, improving diagnostic techniques, and developing prevention strategies. Medical research is typically conducted by teams of researchers including clinicians, scientists, and other healthcare professionals. It is subject to ethical guidelines and regulations to ensure that it is conducted responsibly and with the best interests of patients in mind.

Cadmium is a toxic heavy metal that is a byproduct of the mining and smelting of zinc, lead, and copper. It has no taste or smell and can be found in small amounts in air, water, and soil. Cadmium can also be found in some foods, such as kidneys, liver, and shellfish.

Exposure to cadmium can cause a range of health effects, including kidney damage, lung disease, fragile bones, and cancer. Cadmium is classified as a known human carcinogen by the International Agency for Research on Cancer (IARC) and the National Toxicology Program (NTP).

Occupational exposure to cadmium can occur in industries that produce or use cadmium, such as battery manufacturing, metal plating, and pigment production. Workers in these industries may be exposed to cadmium through inhalation of cadmium-containing dusts or fumes, or through skin contact with cadmium-containing materials.

The general population can also be exposed to cadmium through the environment, such as by eating contaminated food or breathing secondhand smoke. Smoking is a major source of cadmium exposure for smokers and those exposed to secondhand smoke.

Prevention measures include reducing occupational exposure to cadmium, controlling emissions from industrial sources, and reducing the use of cadmium in consumer products. Regular monitoring of air, water, and soil for cadmium levels can also help identify potential sources of exposure and prevent health effects.

Metabolism is the complex network of chemical reactions that occur within our bodies to maintain life. It involves two main types of processes: catabolism, which is the breaking down of molecules to release energy, and anabolism, which is the building up of molecules using energy. These reactions are necessary for the body to grow, reproduce, respond to environmental changes, and repair itself. Metabolism is a continuous process that occurs at the cellular level and is regulated by enzymes, hormones, and other signaling molecules. It is influenced by various factors such as age, genetics, diet, physical activity, and overall health status.

I'm sorry for any confusion, but "Pimelic Acids" is not a recognized medical term or concept in physiology, pathology, or pharmacology. It appears to be a term used in chemistry and biochemistry, referring to a specific type of organic compound known as a dicarboxylic acid with a seven-carbon backbone.

In biochemistry, pimelic acid may be involved in various metabolic processes, such as the synthesis of certain amino acids and lipids. However, it is not typically considered a medical term or diagnostic marker in clinical settings. If you're looking for information related to a specific medical condition or treatment, I would be happy to help if you could provide more context!

In the context of medical laboratory reporting, "R factors" refer to a set of values that describe the resistance of certain bacteria to different antibiotics. These factors are typically reported as R1, R2, R3, and so on, where each R factor corresponds to a specific antibiotic or class of antibiotics.

An R factor value of "1" indicates susceptibility to the corresponding antibiotic, while an R factor value of "R" (or "R-", depending on the laboratory's reporting practices) indicates resistance. An intermediate category may also be reported as "I" or "I-", indicating that the bacterium is intermediately sensitive to the antibiotic in question.

It's important to note that R factors are just one piece of information used to guide clinical decision-making around antibiotic therapy, and should be interpreted in conjunction with other factors such as the patient's clinical presentation, the severity of their infection, and any relevant guidelines or recommendations from infectious disease specialists.

The Amoxicillin-Potassium Clavulanate Combination is an antibiotic medication used to treat various infections caused by bacteria. This combination therapy combines the antibiotic amoxicillin with potassium clavulanate, which is a beta-lactamase inhibitor. The addition of potassium clavulanate helps protect amoxicillin from being broken down by certain types of bacteria that produce beta-lactamases, thus increasing the effectiveness of the antibiotic against a broader range of bacterial infections.

Amoxicillin is a type of penicillin antibiotic that works by inhibiting the synthesis of the bacterial cell wall, ultimately leading to bacterial death. However, some bacteria have developed enzymes called beta-lactamases, which can break down and inactivate certain antibiotics like amoxicillin. Potassium clavulanate is added to the combination to inhibit these beta-lactamase enzymes, allowing amoxicillin to maintain its effectiveness against a wider range of bacteria.

This combination medication is used to treat various infections, including skin and soft tissue infections, respiratory tract infections, urinary tract infections, and dental infections. It's essential to follow the prescribed dosage and duration as directed by a healthcare professional to ensure effective treatment and prevent antibiotic resistance.

Common brand names for this combination include Augmentin and Amoxiclav.

Erythromycin is a type of antibiotic known as a macrolide, which is used to treat various types of bacterial infections. It works by inhibiting the bacteria's ability to produce proteins, which are necessary for the bacteria to survive and multiply. Erythromycin is often used to treat respiratory tract infections, skin infections, and sexually transmitted diseases. It may also be used to prevent endocarditis (inflammation of the lining of the heart) in people at risk of this condition.

Erythromycin is generally considered safe for most people, but it can cause side effects such as nausea, vomiting, and diarrhea. It may also interact with other medications, so it's important to tell your doctor about all the drugs you are taking before starting erythromycin.

Like all antibiotics, erythromycin should only be used to treat bacterial infections, as it is not effective against viral infections such as the common cold or flu. Overuse of antibiotics can lead to antibiotic resistance, which makes it harder to treat infections in the future.

An encyclopedia is a comprehensive reference work containing articles on various topics, usually arranged in alphabetical order. In the context of medicine, a medical encyclopedia is a collection of articles that provide information about a wide range of medical topics, including diseases and conditions, treatments, tests, procedures, and anatomy and physiology. Medical encyclopedias may be published in print or electronic formats and are often used as a starting point for researching medical topics. They can provide reliable and accurate information on medical subjects, making them useful resources for healthcare professionals, students, and patients alike. Some well-known examples of medical encyclopedias include the Merck Manual and the Stedman's Medical Dictionary.

Bacterial drug resistance is a type of antimicrobial resistance that occurs when bacteria evolve the ability to survive and reproduce in the presence of drugs (such as antibiotics) that would normally kill them or inhibit their growth. This can happen due to various mechanisms, including genetic mutations or the acquisition of resistance genes from other bacteria.

As a result, bacterial infections may become more difficult to treat, requiring higher doses of medication, alternative drugs, or longer treatment courses. In some cases, drug-resistant infections can lead to serious health complications, increased healthcare costs, and higher mortality rates.

Examples of bacterial drug resistance include methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococci (VRE), and multidrug-resistant tuberculosis (MDR-TB). Preventing the spread of bacterial drug resistance is crucial for maintaining effective treatments for infectious diseases.

Drug resistance, also known as antimicrobial resistance, is the ability of a microorganism (such as bacteria, viruses, fungi, or parasites) to withstand the effects of a drug that was originally designed to inhibit or kill it. This occurs when the microorganism undergoes genetic changes that allow it to survive in the presence of the drug. As a result, the drug becomes less effective or even completely ineffective at treating infections caused by these resistant organisms.

Drug resistance can develop through various mechanisms, including mutations in the genes responsible for producing the target protein of the drug, alteration of the drug's target site, modification or destruction of the drug by enzymes produced by the microorganism, and active efflux of the drug from the cell.

The emergence and spread of drug-resistant microorganisms pose significant challenges in medical treatment, as they can lead to increased morbidity, mortality, and healthcare costs. The overuse and misuse of antimicrobial agents, as well as poor infection control practices, contribute to the development and dissemination of drug-resistant strains. To address this issue, it is crucial to promote prudent use of antimicrobials, enhance surveillance and monitoring of resistance patterns, invest in research and development of new antimicrobial agents, and strengthen infection prevention and control measures.

Drug delivery systems (DDS) refer to techniques or technologies that are designed to improve the administration of a pharmaceutical compound in terms of its efficiency, safety, and efficacy. A DDS can modify the drug release profile, target the drug to specific cells or tissues, protect the drug from degradation, and reduce side effects.

The goal of a DDS is to optimize the bioavailability of a drug, which is the amount of the drug that reaches the systemic circulation and is available at the site of action. This can be achieved through various approaches, such as encapsulating the drug in a nanoparticle or attaching it to a biomolecule that targets specific cells or tissues.

Some examples of DDS include:

1. Controlled release systems: These systems are designed to release the drug at a controlled rate over an extended period, reducing the frequency of dosing and improving patient compliance.
2. Targeted delivery systems: These systems use biomolecules such as antibodies or ligands to target the drug to specific cells or tissues, increasing its efficacy and reducing side effects.
3. Nanoparticle-based delivery systems: These systems use nanoparticles made of polymers, lipids, or inorganic materials to encapsulate the drug and protect it from degradation, improve its solubility, and target it to specific cells or tissues.
4. Biodegradable implants: These are small devices that can be implanted under the skin or into body cavities to deliver drugs over an extended period. They can be made of biodegradable materials that gradually break down and release the drug.
5. Inhalation delivery systems: These systems use inhalers or nebulizers to deliver drugs directly to the lungs, bypassing the digestive system and improving bioavailability.

Overall, DDS play a critical role in modern pharmaceutical research and development, enabling the creation of new drugs with improved efficacy, safety, and patient compliance.

Drug resistance in neoplasms (also known as cancer drug resistance) refers to the ability of cancer cells to withstand the effects of chemotherapeutic agents or medications designed to kill or inhibit the growth of cancer cells. This can occur due to various mechanisms, including changes in the cancer cell's genetic makeup, alterations in drug targets, increased activity of drug efflux pumps, and activation of survival pathways.

Drug resistance can be intrinsic (present at the beginning of treatment) or acquired (developed during the course of treatment). It is a significant challenge in cancer therapy as it often leads to reduced treatment effectiveness, disease progression, and poor patient outcomes. Strategies to overcome drug resistance include the use of combination therapies, development of new drugs that target different mechanisms, and personalized medicine approaches that consider individual patient and tumor characteristics.

Barber M, Waterworth PM (August 1964). "Penicillinase-resistant Penicillins and Cephalosporins". British Medical Journal. 2 ( ...
Novick, R. P.; Richmond, M. H. (August 1965). "Nature and Interactions of the Genetic Elements Governing Penicillinase ... Novick, Rp (1962-05-01). "Micro-iodometric assay for penicillinase". Biochemical Journal. 83 (2): 236-240. doi:10.1042/ ...
They named the enzyme penicillinase. Penicillinase is now classified as member of enzymes called β-lactamases. These β- ... The reason was discovered as production of an enzyme penicillinase (hence, the first β-lactamase known) in E. coli that easily ... They are also, therefore, referred to as being penicillinase-resistant. This group of antibiotics is called "broad-spectrum" ... Antistaphylococcal antibiotics are so-called because they are resistant to being broken down by staphylococcal penicillinase. ...
Molecular weights of the various penicillinases tend to cluster near 50 kiloDaltons. Penicillinase was the first β-lactamase to ... Penicillinase is a specific type of β-lactamase, showing specificity for penicillins, again by hydrolysing the β-lactam ring. ... Penicillinase-resistant beta-lactams such as methicillin were developed, but there is now widespread resistance to even these. ... Friedlaender S (April 1959). "Penicillinase in the treatment of allergic reactions to penicillin". Journal of Allergy. 30 (2): ...
The former was developed by J. F. Collins to measure penicillinase content of individual Bacillus licheniformis. The latter, ... ISBN 978-0-317-11809-4. Collins, J. F. (1962). "Estimation of penicillinase in single bacterial cells". Biochem. J. 82: 28 P. ...
... is a penicillinase-resistant β-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. ... Since it is resistant to penicillinase enzymes, such as that produced by Staphylococcus aureus, it is widely used clinically in ...
Penicillinase-mediated resistance in N. gonorrhoeae is mediated by the plasmid borne TEM-1 type beta-lactamase which falls ... TEM-1 is a penicillinase specific for penicillins. This enzyme will bind to the beta-lactam ring which is a structural ... The spread of the penicillinase resistance was much faster compared to the chromosomal-mediated resistance mechanisms. The ... Resistance to penicillin has developed through two mechanisms: chromosomally mediated resistance (CMRNG) and penicillinase- ...
Japanese Journal of Tuberculosis 9:11-7. Muftic MK (1962). Isolation and purification of the penicillinase from mycobacteria. ...
... is actually a penicillinase-resistant β-lactam antibiotic. Penicillinase is a bacterial enzyme produced by bacteria ... Methicillin is not bound and hydrolysed by penicillinase, meaning it can kill the bacteria, even if this enzyme is present. ... It was previously used to treat infections caused by susceptible gram-positive bacteria, in particular, penicillinase-producing ... Methicillin is insensitive to beta-lactamase (also known as penicillinase) enzymes secreted by many penicillin-resistant ...
Datta, Naomi; Kontomichalou, Polyxeni (1965). "Penicillinase Synthesis Controlled By Infectious R Factors In Enterobacteriaceae ...
Penicillinase-producing Neisseria gonorrhoeae developed a resistance to penicillin in 1976. Another example is Azithromycin- ...
Positive for β-glucosidase, nitrate reductase, penicillinase, trehalase, urease and iron uptake. Tween 80 hydrolysis after 10 ...
They found that it was resistant to penicillinase produced by gram-positive bacteria. When he returned to Oxford, Florey and ... Abraham and Chain discovered that some airborne bacteria produced penicillinase, an enzyme that destroys penicillin. Heatley ... of experiments that determined that it was not toxic to mice but could protect them against streptococci and penicillinase- ...
Penicillinase production is one mechanism by which bacteria can become penicillin resistant. The principal genes responsible ... Some bacteria have consequently developed the counter-ability to survive penicillin exposure by producing penicillinases, ...
Properties are similar to benzylpenicillin particularly used in streptococcal infections, not resistant to penicillinase. It is ...
Chain and Abraham worked out the chemical nature of penicillinase which they reported in Nature as: The conclusion that the ... Abraham and Chain discovered that some airborne bacteria produced penicillinase, an enzyme that destroys penicillin. It was not ... coli strain that produced the penicillinase enzyme, which was capable of breaking down penicillin and negating its ... designed to counter first-generation-resistant penicillinases, was introduced in the United Kingdom in 1959. Methicillin- ...
It is similar in effect to cloxacillin and dicloxacillin, being active against penicillinase forming bacteria. Flucloxacillin ... Flucloxacillin is insensitive to beta-lactamase (also known as penicillinase) enzymes secreted by many penicillin-resistant ...
In 1940 Abraham discovered penicillinase as the cause of bacterial resistance to antibiotics such as penicillin. In October ... was not degraded by penicillinase and hence able to cure infections from penicillin-resistant bacteria. During a skiing holiday ...
Watanakunakorn C, Bakie C (May 1973). "Coagulase production, mannitol fermentation, penicillinase elaboration, and phage ...
Most strains of S. aureus implicated in SSSS have penicillinases, so are penicillin resistant. Therefore, treatment with ...
... also known as penicillinase) enzymes secreted by many penicillin-resistant bacteria. The presence of the isoxazolyl group on ...
These methoxy groups allow methicillin to be used against penicillinase producing bacteria that would otherwise be resistant to ...
... penicillinase-and non-penicillinase-producing isolates). Skin and soft tissue infection: effective against group A and B beta- ...
... penicillinase-resistant penicillin, or cephalosporins." Oral antibiotics work best in combination with a topical antibiotic ...
Antimicrobial options include penicillinase-resistant penicillins (ex: cloxacillin, dicloxacillin) or a combination of a ...
Some patients may benefit from systemic narrow-spectrum penicillinase-resistant penicillins (such as dicloxacillin in the US or ...
Beta-lactamases (such as penicillinases) formed by gram-positive and gram-negative bacteria can stabilize doripenem to ...
Penicillinase-resistant β-lactam antibiotics, such as methicillin, nafcillin, oxacillin, cloxacillin, dicloxacillin, and ... Staphylococcal resistance to penicillin is mediated by penicillinase (a form of beta-lactamase) production: an enzyme that ... and first-line therapy is most commonly a penicillinase-resistant β-lactam antibiotic (for example, oxacillin or flucloxacillin ... flucloxacillin are able to resist degradation by staphylococcal penicillinase.[citation needed] Resistance to methicillin is ...
Cephalosporin: This is an example of a wide spectrum antibiotic that is relatively stable to staphylococcal penicillinase ...
Antibiotics choices depend on regional availability, but a penicillinase-resistant semisynthetic penicillin or a first- ...
Penicillins, Penicillinase Resistant. Class Summary. The penicillinase-resistant, or second-generation, penicillins are ... It is used in the treatment of infections caused by penicillinase-producing staphylococci. It may be used to initiate therapy ... It is used for the treatment of infections caused by streptococci and penicillinase-producing staphylococci. It may be used to ... It is used for the treatment of infections caused by streptococci or penicillinase-producing staphylococci. It may be used to ...
Incidence of penicillinase producing Neisseria gonorrhoeae (PPNG) strains and susceptibility of gonococcal isolates to ... Incidence of penicillinase producing Neisseria gonorrhoeae (PPNG) strains and susceptibility of gonococcal isolates to ... and the penicillinase stable cephalosporins. The high incidence of resistance may have been the result of indiscriminate and ... produced penicillinase. The minimum inhibitory concentrations (MICs) of penicillin G and ampicillin for these isolates were ...
... Validated for WB, ELISA, IP. Tested in Enterobacter cloacae. Order online. ... 抗原 See all Penicillinase products Penicillinase 适用 All reactivities for Penicillinase 抗体 * Enterobacter cloacae 6 ... This Penicillinase antibody is un-conjugated 应用范围 All applications for Penicillinase 抗体 * ELISA 6 ... Penicillinase Abstract Penicillinase 产品 别名 beta-lactamase TEM-1 antibody, blaTEM-1 antibody ...
PENICILLINASE,Penicillinase,canSAR2741405 , Compound overview, Drug targets, Compound forms, Similar compounds , canSARS ...
View the list of generic medicines under the Penicillins-Semisynthetic Penicillinase Resistantcategory. ... Penicillins-Semisynthetic Penicillinase Resistant. Generic Medicines In Category Penicillins-Semisynthetic Penicillinase ...
Contact us Now to know more about Penase Penicillinase ... and Supplier of Penase Penicillinase in Zhejiang , China . ...
JOINT ELIMINATION AND JOINT TRANSDUCTION OF THE DETERMINANTS OF PENICILLINASE PRODUCTION AND RESISTANCE TO MACROLIDE ... JOINT ELIMINATION AND JOINT TRANSDUCTION OF THE DETERMINANTS OF PENICILLINASE PRODUCTION AND RESISTANCE TO MACROLIDE ...
Home Type Contact Plate TSA + Penase (Tryptone Soya Agar + Penicillinase), Contact Plate, Irradiated. ... TSA + Penase (Tryptone Soya Agar + Penicillinase), Contact Plate, Irradiated. Highly nutritious general purpose medium for the ... growth of bacteria and fungi in a contact plate to permit direct environmental sampling, with penicillinase to neutralise ...
Barber M, Waterworth PM (August 1964). "Penicillinase-resistant Penicillins and Cephalosporins". British Medical Journal. 2 ( ...
Penicillinase, gentamicin, glycopeptides. Streptococcus groups A, C, G. Penicillins. Listeria monocytogenes. Penicillins, ...
Penicillinase / analysis* * Pseudomonas aeruginosa / enzymology * Spectrophotometry * Staphylococcus / enzymology Substances * ...
Penicillinase resistant penicillins Pregnancy Category. B - No proven risk in humans CSA Schedule. Not a controlled drug ... penicillinase resistant penicillins. There is no proven risk in humans during pregnancy. Dicloxacillin 500 mg is not a ...
Of 75 CipR/CipI isolates, 48 (64%) were resistant to penicillin; 28 (37%) were penicillinase-producing N. gonorrhoeae. In ...
It is stable against hydrolysis by a variety of beta-lactamases, including penicillinases, cephalosporinases, and extended- ...
Drug eruptions can mimic a wide range of dermatoses. The morphologies are myriad and include morbilliform (most common, see image below), urticarial, papulosquamous, pustular, and bullous.
Penicillinase_R. Penicillinase repressor. ENSMLUP00000002019. PF04977. 0.00024. DivIC. Septum formation initiator. Gene ...
Staphylococci, including penicillinase-producing strains Streptococcus (Diplococcus) pneumoniae Escherichia coli Proteus ...
Penicillinase Resistant Penicillins. Application Segments of the Penicillin Market. Hospitals. Clinics. Others. Regional ...
Infections due to penicillinase-producing Neisseria gonorrhoeae in the United States: 1976-1980. J Infect Dis 1981;144:191-7. ... surveillance of penicillinase-producing N. gonorrhoeae (PPNG) was conducted by health departments and incorporated into case ...
Respiratory tract Infections caused by S. pneumoniae (formerly D. pneumoniae). Staphylococcus aureus (penicillinase and ...
Susceptible infections due to penicillinase-producing staphylococci.. Adult Dosage: Give by deep IM gluteal inj or IV infusion ...
Timeline for Species Bacillus licheniformis [TaxId:1402] from a.4.5.39 Penicillinase repressor BlaI: *Species Bacillus ... Family a.4.5.39: Penicillinase repressor [101016] (3 proteins). homologous to the MarR-like family in the DNA-binding region ... Protein Penicillinase repressor BlaI [101019] (2 species). *. Species Bacillus licheniformis [TaxId:1402] [101020] (2 PDB ... Species Bacillus licheniformis [TaxId:1402] from a.4.5.39 Penicillinase repressor BlaI appears in SCOP 1.73. *Species Bacillus ...
Stable to staphylococcal penicillinase, • Being more resistant to the action of β-lactamases, • Producing fewer ...
However, many S. aureus strains, while resistant to penicillin, remain susceptible to penicillinase-stable penicillins, such as ... This phenomenon is termed heteroresistance and occurs in staphylococci resistant to penicillinase-stable penicillins, such as ...
A screening method for beta-lactams in tissues hydrolyzed with penicillinase I and lactamase II. Medina MB, Poole DJ, Anderson ...
Dicloxacillin is used in the treatment of infections caused by penicillinase-producing staphylococci. It may be used to ...
Acute, uncomplicated ano-rectal infections in women due to Neisseria gonorrhoeae (including penicillinase-producing strains). ... Neisseria gonorrhoeae (including penicillinase-producing isolates) The following in vitro data are available, but their ... Uncomplicated skin and skin structure infections caused by Staphylococcus aureus (including penicillinase-producing strains) or ... Acute, uncomplicated urethral and cervical gonorrhea caused by Neisseria gonorrhoeae (including penicillinase-producing strains ...
Kubiak DW Arnaout RA Hammond SP Pharmacology of Bacterial and Mycobacterial Infections: Cell Wall Synthesis in Principles of Pharmacology: The Pathophysiologic Basis of Drug Therapy. (Golan DE, editor-in chief, Armstrong EJ Armstrong AW, associate editors) 4e Wolters Kluwer 2017. ...
Staphylococcus aureus (including penicillinase-producing strains). Streptococcus pneumoniae (penicillin-susceptible strains). ...
Outbreak of a distinct strain of penicillinase-producing Neisseria gonorrhoeae--King County, Washington. MMWR 1987;36:757-9. * ...
  • Acute, uncomplicated urethral and cervical gonorrhea caused by Neisseria gonorrhoeae (including penicillinase-producing strains). (globalrph.com)
  • Acute, uncomplicated ano-rectal infections in women due to Neisseria gonorrhoeae (including penicillinase-producing strains). (globalrph.com)
  • Staphylococcus aureus (penicillinase and nonpenicillinase-producing), H. influenzae, and Group A beta-hemolytic Streptococci. (nih.gov)
  • James Hadler] Well, MRSA is nothing more or less than Staphylococcus aureus , with resistance to a specific class of antibiotics, penicillinase-resistant penicillins. (cdc.gov)
  • It has shown efficacy against a variety of Streptococcus species as well as non-penicillinase producing Staphylococcus species. (goldbio.com)
  • Perfil de resistencia de Staphylococcus spp aislados de hemocultivos en el Hospital Centra. (bvsalud.org)
  • Las infecciones nosocomiales por Staphylococcus spp constituyen uno de los problemas de mayor preocupación en salud pública en todo el mundo. (bvsalud.org)
  • Debido a que existen diferencias según centro hospitalario, paciente, área y tiempo de internación es esencial conocer el perfil de resistencia a los antibióticos más utilizados de las cepas de Staphylococcus involucradas en estas infecciones. (bvsalud.org)
  • El objetivo del presente estudio fue determinar el perfil de resistencia de los aislados de Staphylococcus aureus (Sau) y Estafilococo coagulasa negativo (ECN) de muestras de hemocultivos de pacientes adultos, pediátricos y recién nacidos internados entre el 1 de junio de 2005 al 30 de junio de 2006, en varios servicios del Hospital Central del Instituto de Previsión Social (IPS. (bvsalud.org)
  • No isolates were resistant to vancomycin which is still the best antibiotic available for the treatment of infections due to penicillin resistant Staphylococcus that are inhibited by penicillinase. (bvsalud.org)
  • The penicillinase-resistant, or second-generation, penicillins are semisynthetic modifications of natural penicillins that are resistant to bacterial enzyme beta-lactamase, which accounts for typical penicillin resistance. (medscape.com)
  • Pneumonia and belongs to the drug class penicillinase resistant penicillins . (drugs.com)
  • However, many S. aureus strains, while resistant to penicillin, remain susceptible to penicillinase-stable penicillins, such as oxacillin and methicillin. (cdc.gov)
  • This phenomenon is termed heteroresistance and occurs in staphylococci resistant to penicillinase-stable penicillins, such as oxacillin. (cdc.gov)
  • Incidence of penicillinase producing Neisseria gonorrhoeae (PPNG) strains and susceptibility of gonococcal isolates to antibiotics in Benin City, Nigeria. (bmj.com)
  • Of 53 strains of Neisseria gonorrhoeae isolated in Benin City, Nigeria, in February 1983 to October 1984, 46 (87%) produced penicillinase. (bmj.com)
  • About 48% (22/46) of the penicillinase producing strains were also resistant to streptomycin, cotrimoxazole, and ampicillin and cloxacillin. (bmj.com)
  • It is not active against the penicillinase-producing bacteria, which include many strains of staphylococci. (pediatriconcall.com)
  • including strains producing and not producing penicillinase, methicillin-resistant strains), some strains of Enterococcus spp. (jcenonline.com)
  • Highly nutritious general purpose medium for the growth of bacteria and fungi in a contact plate to permit direct environmental sampling, with penicillinase to neutralise penicillin. (sglab.com)
  • Penicillinase-resistant penicillin. (renalandurologynews.com)
  • It is used in the treatment of infections caused by penicillinase-producing staphylococci. (medscape.com)
  • Susceptible infections due to penicillinase-producing staphylococci. (renalandurologynews.com)
  • Figure 10 shows the proportions of gonococci fully sensitive (MIC ≤ 0.03 mg/L), less sensitive (MIC 0.06 - 0.5 mg/L), relatively resistant (MIC ≥ 1 mg/L) or else penicillinase producing (PPNG) aggregated for Australia and by State or Territory. (health.gov.au)
  • Unlike most coagulase-negative staphylococcal species, S. lugdunensis often remains sensitive to penicillinase-resistant beta-lactam antibiotics (ie, methicillin-sensitive). (merckmanuals.com)
  • AMPICILLIN does not resist destruction by penicillinase. (nih.gov)
  • Increased ampicillin resistance was due to increased penicillinase activity of the bacteria. (microbiologyresearch.org)
  • Treatment is usually with penicillinase-resistant beta-lactams, but because antibiotic resistance is common, vancomycin or other newer antibiotics may be required. (merckmanuals.com)
  • It is stable against hydrolysis by a variety of beta-lactamases, including penicillinases, cephalosporinases, and extended-spectrum beta-lactamases. (medscape.com)
  • During the first 9 months of 1985, CDC received reports of 6,020 cases of penicillinase-producing Neisseria gonorrhoeae (PPNG) among civilians, over twice the 2,973 cases reported for the same period in 1984. (cdc.gov)
  • Penicillinase-producing Neisseria gonorrhoeae (PPNG) number of reported cases United States: calendar years 1976-1983. (cdc.gov)
  • Penicillinase-producing Neisseria gonorrhoeae isolated in Surabaya. (bmj.com)
  • Although penicillinase-producing strains of Neisseria gonorrhoeae (PPNG) were discovered in 1976 in neighbouring countries, not until 1980 were such strains isolated and identified in Indonesia. (bmj.com)
  • Five of the nine strains were penicillinase-producing Neisseria gonorrhoeae. (bmj.com)
  • Acute, uncomplicated urethral and cervical gonorrhea caused by Neisseria gonorrhoeae (including penicillinase-producing strains). (druglib.com)
  • Acute, uncomplicated ano-rectal infections in women due to Neisseria gonorrhoeae (including penicillinase-producing strains). (druglib.com)
  • They are, however, susceptible to beta-lactamase (penicillinase) hydrolysis. (msdvetmanual.com)
  • These antibiotics are resistant to penicillinases and cephalosporins [5]. (researchsquare.com)
  • It is a penicillinase-resistant, acid resistant semisynthetic penicillin suitable for oral administration. (nih.gov)
  • Penicillin that is resistant to staphylococcal penicillinase. (e-lactancia.org)
  • A positive feature of these drugs is that they display a resistance to penicillinases and are useful to treat infections that are resistant to penicillin derivatives. (fsu.edu)
  • Penicillinase-resistant β lactams such as methicillin were developed, but there is now widespread resistance to even these (for example, MRSA ). (wikidoc.org)
  • Penicillinase-resistant penicillin used widely in cellulitis, otitis externa and impetigo. (ggcmedicines.org.uk)
  • Dale J.W. 1970 The purification and properties of penicillinases from penicillin-resistant Gramnegative bacteria, some of which harbour R-factors. (microbiologyresearch.org)
  • penicillinase and non-penicillinase producing, including methicillin resistant). (myvmc.com)
  • Liberation of extracellular penicillinase during the process of enzyme induction in penicillase producing bacteria]. (nih.gov)
  • To overcome the penicillinase resistance mechanism, scientists at Beecham Laboratories redesigned the penicillin molecule, leading to the introduction of a new compound, methicillin, in 1957. (project-syndicate.org)
  • How does B-lactamase/penicillinase (lamB gene) provide bacteria resistance to penicillin? (brainscape.com)
  • This product is isolated and purified from recombinant E. coli, and obtained sterile penicillinase solution after filtration. (kekaibio.com)
  • Penicillinase was the first β-lactamase to be identified: it was first isolated by Abraham and Chain in 1940 from gram-negative E. coli even before penicillin entered clinical use [1] but penicillinase production quickly spread to bacteria that previously did not produce it or only produced it rarely. (wikidoc.org)
  • Combined induction of penicillinase in Bacillus cereus by means of various inducers. (nih.gov)
  • ELISA assay with penicillinase as the marker enzyme. (kekaibio.com)
  • A bacteria might aquire the lamB gene via horizontal gene transfer allowing it to produce penicillinase/B-lactamase enzyme. (brainscape.com)
  • Penicillinase, also known as penicillinase β- Lactamase, penicillin amino β- Lactam hydrolases are widely distributed in various microorganisms, especially in bacteria. (kekaibio.com)
  • Group 2 are penicillinases, cephalosporinases, or both inhibited by clavulanic acid, corresponding to the molecular classes A and D reflecting the original TEM and SHV genes. (wikidoc.org)